This page collects WhisperX intelligence signals tagged #Pharmaceutical. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
The U.S. Food and Drug Administration (FDA) has issued a second formal warning letter to pharmaceutical giant Novo Nordisk regarding its promotional activities for the GLP-1 drug Ozempic (semaglutide). The regulatory action cites violations related to misleading claims and inadequate risk disclosure in the company's ad...
Pfizer and its German partner BioNTech have been forced to abandon a critical clinical trial for an updated COVID-19 vaccine, citing a complete failure to enroll enough participants. The study, targeting adults aged 50 to 64, was scrapped because the companies could not generate the necessary data. This trial was a dir...
Eli Lilly has entered a collaboration with AI-focused biotech Profluent to develop next-generation gene editors capable of inserting entire genes into patients, signaling a major escalation in the pharmaceutical giant's ambitions in genetic medicine. The deal structure includes up to $2.25 billion in milestone payments...
KalVista Pharmaceuticals saw its shares climb sharply after the company entered into a definitive agreement to be acquired by Chiesi, the Italy-based global pharmaceutical group, in a transaction valued at approximately $1.9 billion. The deal signals a notable consolidation move in the biotech sector, with KalVista sha...
Jaguar Health, Inc. has received formal notice from its listing exchange regarding failure to satisfy continued listing standards, triggering immediate regulatory scrutiny and raising serious questions about the company's future on public markets. The SEC filing, submitted on May 4, 2026, confirms the company faces pot...
West Pharmaceutical Services, a major Pennsylvania-based pharmaceutical manufacturer, disclosed a ransomware attack that has disrupted global shipping, receiving, and manufacturing operations. The company filed an 8-K form with the Securities and Exchange Commission (SEC) on Monday evening, revealing that threat actors...
West Pharmaceutical Services, a major player in the pharmaceutical manufacturing sector, fell victim to a sophisticated cybersecurity breach on May 4, 2026. Attackers successfully infiltrated the company's systems, encrypted critical data, and exfiltrated sensitive information before the intrusion was identified. The s...
Takeda Pharmaceutical, Japan's largest drugmaker, has unveiled plans to eliminate approximately 4,500 positions as part of a sweeping restructuring initiative the company frames as a strategic pivot toward what executives describe as a "new era" of operations. The layoffs represent a significant workforce contraction f...